TRCT
DXCM icon

Tower Research Capital (TRC)’s DexCom DXCM Stock Holding History

Tower Research Capital (TRC)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$38.6K – 5999
2023
Q2 		$38.6K Buy
+300
New +$36.3K ﹤0.01% 2805

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Tower Research Capital (TRC)'s DXCM Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its DexCom (DXCM) stake by 79% in Q2 2026, selling an estimated $1.72M and leaving 6,808 shares worth $459K. The position accounts for 0.01% of the portfolio, ranked #1090.

Tower Research Capital (TRC) first reported a position in DXCM in Q2 2013 and has held it in 45 quarters since. The position peaked at $13.5M in Q1 2022. 975 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Tower Research Capital (TRC) held 6,808 shares of DexCom worth $459K as of Q2 2026.
  • Tower Research Capital (TRC) sold 25,748 DexCom shares in Q2 2026, an estimated $1.72M.
  • DexCom made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1090 holding.
  • Tower Research Capital (TRC) first reported a position in DexCom in Q2 2013 and has held it in 45 quarters since.
  • Tower Research Capital (TRC)'s DexCom position peaked at $13.5M in Q1 2022.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.